Skip to main content
Premium Trial:

Request an Annual Quote

Rhone-Poulenc Signs Global Site License for Bioinformatics Software

Premium

COLLEGEVILLE, Pa.--Rhone-Poulenc Rorer, a major international pharmaceutical company based here, last week announced that it has signed an unlimited worldwide site license for the Vector NTI Deluxe bioinformatics software, which is distributed by InforMax. "The global installation of the Vector NTI software at RPR fills an important need in RPR's bioinformatics strategy," commented Peter Loupos, the company's senior director for information technology in its pharmaceutical discovery division. "We expect this product to help us achieve significant efficiencies in designing gene-related treatments through computer simulation."

Bethesda, Md., based InforMax develops genetic software and provides system development and integration for the bioinformatics needs of pharmaceutical and biotechnology companies around the world.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.